Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Women's Health
Published in: BMC Women's Health 1/2010

Open Access 01-12-2010 | Research article

Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women

Authors: Gregory D Zimet, Thomas W Weiss, Susan L Rosenthal, Margaret B Good, Michelle D Vichnin

Published in: BMC Women's Health | Issue 1/2010

Login to get access

Abstract

Background

Despite CDC recommendations regarding universal catch-up vaccination against human papillomavirus (HPV), only about ten percent of young adult women in the United States have been vaccinated. The purpose of this study was to better understand reasons for non-vaccination among insured 19-26 year-old women and to evaluate future vaccination intentions.

Methods

We used an administrative claims database from a large US managed care plan to identify women aged 19-26 for receipt of a mailed survey. From a sample of 1,375 women with no evidence of HPV vaccination from June 1, 2006 through April 30, 2007, 222 completed surveys were received, of which 185 were eligible for this analysis. The main outcome measures were unvaccinated women's attitudes and vaccine awareness, likelihood of future action regarding the vaccine, and reasons for inaction.

Results

Among the 185 non-vaccinees, 25.4% were married, 83.2% were white, and 89.2% had a college or higher level education. The vaccine was described as very important by 32.4% of subjects, and 30.1% had discussed the vaccine with a doctor and received a doctor's recommendation. Half or fewer of respondents were "very" or "extremely" likely to discuss the vaccine with their doctor (50.0%), do additional research on the vaccine (42.6%), ask a doctor to get the vaccine (37.5%), or make an appointment to get the vaccine (27.8%), while 48.0% were "somewhat", "very", or "extremely" likely to do nothing to get the vaccine. Among the latter, reasons for taking no action included being married or in a monogamous relationship (54.9%), belief that the vaccine is too new (35.4%), not having enough information about the vaccine (31.7%), concerns about side effects (24.4%), and uncertainty about insurance coverage (24.4%).

Conclusions

Educational interventions may be needed to enhance HPV vaccination rates among 19-26 year-old women, particularly regarding information about vaccine safety, vaccine efficacy, insurance coverage, and the value of vaccination to women in monogamous relationships.
Appendix
Available only for authorised users
Literature
1.
Weinstock H, Berman S, Cates W: Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004, 36: 6-10. 10.1363/3600604.CrossRefPubMed
2.
Huang CM: Human papillomavirus and vaccination. Mayo Clinic Proc. 2008, 83: 701-707. 10.4065/83.6.701.CrossRef
3.
Castellsague X: Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol. 2008, 110 (3 Suppl 2): S4-7. 10.1016/j.ygyno.2008.07.045.CrossRefPubMed
4.
Harper DM: Impact of vaccination with Cervarix (Trade Mark) on subsequent HPV-16/18 infection and cervical disease in women 15-25 years of age. Gynecol Oncol. 2008, 110 (3 Suppl 1): S11-17. 10.1016/j.ygyno.2008.06.029.CrossRefPubMed
5.
6.
Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GWK, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelsom M, Boslego J, Sattler C, Barr E, Koutsky LA: Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007, 356: 1928-1943. 10.1056/NEJMoa061760.CrossRefPubMed
7.
FUTURE II Study Group: Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007, 356: 1915-1927. 10.1056/NEJMoa061741.CrossRef
8.
9.
10.
Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER: Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007, 56 (RR-2): 1-24.PubMed
11.
Centers for Disease Control and Prevention: FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP) & FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR. 2010, 59: 626-32.
12.
Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet GD: Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol. 2008, 111: 1103-1110. 10.1097/AOG.0b013e31817051fa.CrossRefPubMed
13.
Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S, Kahn JA: Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Women's Health. 2009, 18: 1679-1686. 10.1089/jwh.2008.1329.CrossRef
14.
Grant D, Kravitz-Wirtz N, Breen N, Tiro JA, Tsui J: One in four California adolescent girls have had human papillomavirus vaccination. Policy Brief UCLA Cent Health Policy Res. 2009, 1-6. PB2009-3
15.
Jain N, Euler GL, Shefer A, Lu P, Yankey D, Markowitz L: Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev Med. 2009, 48: 426-431. 10.1016/j.ypmed.2008.11.010.CrossRefPubMed
16.
Adams M, Jasani B, Fiander A: Prophylactic HPV vaccination for women over 18 years of age. Vaccine. 2009, 27: 3391-3394. 10.1016/j.vaccine.2009.01.067.CrossRefPubMed
17.
Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD: Predictors of HPV Vaccine Uptake among Women Ages 19-26: Importance of a Physician's Recommendation. Vaccine. 2010, ed2010
18.
Armitage CJ, Conner M: Efficacy of the theory of planned behaviour: A meta-analytic review. Br J Soc Psychol. 2001, 40: 471-500. 10.1348/014466601164939.CrossRefPubMed
19.
Allen JD, Mohllajee AP, Shelton RC, Othus MK, Fontenot HB, Hanna R: Stage of adoption of the human papillomavirus vaccine among college women. Prev Med. 2009, 48: 420-425. 10.1016/j.ypmed.2008.12.005.CrossRefPubMed
20.
Zimet GD: Understanding and overcoming barriers to human papillomavirus vaccine acceptance. Curr Opin Obstet Gynecol. 2006, 18 (Suppl 1): s23-28. 10.1097/01.gco.0000216317.10690.8f.CrossRefPubMed
21.
Brewer NT, Fazekas KI: Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007, 45: 107-114. 10.1016/j.ypmed.2007.05.013.CrossRefPubMed
22.
Kahn JA, Rosenthal SL, Hamann T, Bernstein DI: Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS. 2003, 14: 300-306. 10.1258/095646203321605486.CrossRefPubMed
23.
Boehner CW, Howe SR, Bernstein DI, Rosenthal SL: Viral sexually transmitted disease vaccine acceptability among college students. Sex Transm Dis. 2003, 30: 774-778. 10.1097/01.OLQ.0000078823.05041.9E.CrossRefPubMed
24.
Walsh CD, Gera A, Shah M, Sharma A, Powell JE, Wilson S: Public knowledge and attitudes towards human papilloma virus (HPV) vaccination. BMC Public Health. 2008, 8: 368-10.1186/1471-2458-8-368.CrossRefPubMedPubMedCentral
25.
Brabin L, Roberts SA, Stretch R, Baxter D, Chambers G, Kitchener H, McCann R: Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: Prospective cohort study. BMJ. 2008, 336: 1056-1058. 10.1136/bmj.39541.534109.BE.CrossRefPubMedPubMedCentral
26.
Crosbie EJ, Brabin L: Cervical cancer: Problem solved? Vaccinating girls against human papillomavirus. BJOG. 2010, 117: 137-142. 10.1111/j.1471-0528.2009.02369.x.CrossRefPubMed
27.
Marshall H, Ryan P, Roberton D, Baghurst P: A cross-sectional survey to assess community attitudes to introduction of Human papillomavirus vaccine. Aust N Z J Public Health. 2007, 31: 235-242. 10.1111/j.1467-842X.2007.00054.x.CrossRefPubMed
28.
Reeve C, De La Rue S, Pashen D, Culpan M, Cheffins T: School-based vaccinations delivered by general practice in rural north Queensland: An evaluation of a new human papilloma virus vaccination program. Commun Dis Intell. 2008, 32: 94-98.
29.
Dempsey AF: Human papillomavirus: The usefulness of risk factors in determining who should get vaccinated. Rev Obstet Gynecol. 2008, 1: 122-128.PubMedPubMedCentral
Metadata
Title
Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women
Authors
Gregory D Zimet
Thomas W Weiss
Susan L Rosenthal
Margaret B Good
Michelle D Vichnin
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2010
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/1472-6874-10-27

Other articles of this Issue 1/2010

BMC Women's Health 1/2010 Go to the issue

Research article

Menopause status and attitudes in a Turkish midlife female population: an epidemiological study

Research article

A multicentre matched case control study of risk factors for Preeclampsia in healthy women in Pakistan

Research article

Comparing urine samples and cervical swabs for Chlamydia testing in a female population by means of Strand Displacement Assay (SDA)

Research article

New paradigm old thinking: the case for emergency obstetric care in the prevention of maternal mortality in Nigeria

Research article

A cross-sectional study on health and physical functioning in relation to coping strategies among community-dwelling, ethnically diverse older women

Research article

Women, poverty and adverse maternal outcomes in Nairobi, Kenya